BCM TECHNOLOGIES (BCMT)
BCM Technologiesโ investment strategy revolves around the concept that maximum returns from early stage life science investing will result from impeccable diligence and a solid understanding of the underlying science. BCMT likes to invest early and create substantial value by leveraging the experience of the team to guide the company through the start-up process and avoid common mistakes. Success at such an early stage requires constant rationalization of investments and extreme discipline to ... focus on the likely winners. BCMT is a true "early-stage investor" that provides seed capital to perform value creating proof-of-concept research and plays a major role in the structuring and development of the start-up company. The initial investment from BCMT is often made for the specific goal of validating the technology through highly focused research activities and initial investment frequently precedes recruitment of a management team. BCMT prefers to lead Seed and First rounds and will continue to co-invest in later rounds.
BCM TECHNOLOGIES (BCMT)
Founded:
1983-01-01
Status:
Closed
Contact:
(713) 795-0105
Technology used in webpage:
SPF Amazon Pound Sterling Japanese Yen Amazon Ohio Region NameBright
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2006-10-22 | Relievant Medsystems | BCM Technologies (BCMT) investment in Series B - Relievant Medsystems | 5.05 M USD |
2004-06-23 | Rejuvenon | BCM Technologies (BCMT) investment in Series B - Rejuvenon | 37 M USD |
1999-01-01 | Lexicon Pharmaceuticals | BCM Technologies (BCMT) investment in Post-IPO Equity - Lexicon Pharmaceuticals | 31.8 M USD |